Locally advanced HER2-positive breast carcinoma

Clinical trials for Locally advanced HER2-positive breast carcinoma explained in plain language.

Never miss a new study

Get alerted when new Locally advanced HER2-positive breast carcinoma trials appear

Sign up with your email to follow new studies for Locally advanced HER2-positive breast carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Terminated 1

New drug cocktail shows promise for Hard-to-Treat breast cancer

Disease control Stopped early

This study tested a combination of three drugs—tucatinib, trastuzumab, and vinorelbine—in 13 people with HER2-positive breast cancer that had spread or could not be surgically removed. The goal was to see how many patients' tumors shrank or disappeared. The trial was terminated e…

Matched conditions: LOCALLY ADVANCED HER2-POSITIVE BREAST CARCINOMA

Phase 2 • Sponsor: Spanish Breast Cancer Research Group • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

Locally advanced HER2-positive breast carcinoma

Get alerted when new Locally advanced HER2-positive breast carcinoma trials appear

New drug cocktail shows promise for Hard-to-Treat breast cancer